Patents by Inventor Michael J. McGINITY

Michael J. McGINITY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
    Patent number: 11229599
    Abstract: The present invention provides, in some aspects, bilayered and trilayered pharmaceutical implant compositions for the unidirectional delivery of anti-cancer compounds to the brain over a period of time (e.g., several weeks, 1, 2, 3, 4, 5, 6, 7 days, or 1, 2, 3, weeks, or any range derivable therein) following the removal of glioblastoma multiforme or other malignant tumors in the brain.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: January 25, 2022
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Michael J. McGinity, Feng Zhang, John R. Floyd, James W. McGinity
  • IMPLANT COMPOSITIONS FOR THE UNIDIRECTIONAL DELIVERY OF THERAPEUTIC COMPOUNDS TO THE BRAIN
    Publication number: 20200138707
    Abstract: The present invention provides, in some aspects, bilayered and trilayered pharmaceutical implant compositions for the unidirectional delivery of anti-cancer compounds to the brain over a period of time (e.g., several weeks, 1, 2, 3, 4, 5, 6, 7 days, or 1, 2, 3, weeks, or any range derivable therein) following the removal of glioblastoma multiforme or other malignant tumors in the brain.
    Type: Application
    Filed: October 4, 2019
    Publication date: May 7, 2020
    Applicant: Board of Regents, the University of Texas System
    Inventors: Michael J. McGINITY, Feng ZHANG, John R. FLOYD, James W. McGINITY
  • Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
    Patent number: 10434063
    Abstract: The present invention provides, in some aspects, bilayered and trilayered pharmaceutical implant compositions for the unidirectional delivery of anti-cancer compounds to the brain over a period of time (e.g., several weeks, 1, 2, 3, 4, 5, 6, 7 days, or 1, 2, 3, weeks, or any range derivable therein) following the removal of glioblastoma multiforme or other malignant tumors in the brain.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: October 8, 2019
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Michael J. McGinity, Feng Zhang, John R. Floyd, James W. McGinity
  • IMPLANT COMPOSITIONS FOR THE UNIDIRECTIONAL DELIVERY OF THERAPEUTIC COMPOUNDS TO THE BRAIN
    Publication number: 20180311157
    Abstract: The present invention provides, in some aspects, bilayered and trilayered pharmaceutical implant compositions for the unidirectional delivery of anti-cancer compounds to the brain over a period of time (e.g., several weeks, 1, 2, 3, 4, 5, 6, 7 days, or 1, 2, 3, weeks, or any range derivable therein) following the removal of glioblastoma multiforme or other malignant tumors in the brain.
    Type: Application
    Filed: March 21, 2018
    Publication date: November 1, 2018
    Applicant: Board of Regents, the University of Texas System
    Inventors: Michael J. McGINITY, Feng ZHANG, John R. FLOYD, James W. McGINITY
  • Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
    Patent number: 9956172
    Abstract: The present invention provides, in some aspects, bilayered and trilayered pharmaceutical implant compositions for the unidirectional delivery of anti-cancer compounds to the brain over a period of time (e.g., several weeks, 1, 2, 3, 4, 5, 6, 7 days, or 1, 2, 3, weeks, or any range derivable therein) following the removal of glioblastoma multiforme or other malignant tumors in the brain.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: May 1, 2018
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Michael J. McGinity, Feng Zhang, John R. Floyd, James W. McGinity
  • IMPLANT COMPOSITIONS FOR THE UNIDIRECTIONAL DELIVERY OF THERAPEUTIC COMPOUNDS TO THE BRAIN
    Publication number: 20170027864
    Abstract: The present invention provides, in some aspects, bilayered and trilayered pharmaceutical implant compositions for the unidirectional delivery of anti-cancer compounds to the brain over a period of time (e.g., several weeks, 1, 2, 3, 4, 5, 6, 7 days, or 1, 2, 3, weeks, or any range derivable therein) following the removal of glioblastoma multiforme or other malignant tumors in the brain.
    Type: Application
    Filed: July 28, 2016
    Publication date: February 2, 2017
    Applicant: Board of Regents, the University of Texas System
    Inventors: Michael J. McGINITY, Feng ZHANG, John R. FLOYD, James W. McGINITY